Lice clinic marketing: guarantees and one-visit claims

Head lice clinics and in-home lice removal services sell to parents who usually want one thing: the problem gone, today. Their ads reflect that: “guaranteed lice-free,” “one visit and done,” “pesticide-free and non-toxic,” “no-nit school clearance,” “FDA-approved treatment.” Each of those phrases is a claim a regulator can ask you to back up, and several of them collide with what CDC tells parents and schools.

This guide covers what CDC says about head lice and treatment, how FDA classifies lice combs and heated-air devices, and how FTC rules apply to guarantees, safety claims, reviews and prices. We do not name any clinic, franchise, product or company. Pediatric practices that see lice cases should also read our guide to marketing a pediatric practice.

The short version

• CDC is calm about lice. It says head lice do not transmit any disease and are not considered a health hazard, and that getting lice is not related to cleanliness. Fear-based ads cut against the federal health message.
• A guarantee must mean what it says. If you say “guaranteed,” say exactly what you guarantee, for how long, and what the client must do, in the ad itself (16 CFR 239.3 as a model; 15 USC 45).
• “One visit” needs care. CDC lists reinfestation and not following instructions among the reasons treatment fails, and recommends nit checks every 2 to 3 days for 2 to 3 weeks after treatment.
• “Non-toxic” is a defined risk. The FTC says a non-toxic claim likely conveys safety for humans and the environment and needs competent and reliable scientific evidence (16 CFR 260.10).
• Cleared is not approved. A device cleared through a 510(k) is not “FDA-approved,” and implying official approval is misbranding (21 CFR 807.97).

What CDC tells parents

Your ads compete with CDC’s own pages, which parents and school nurses read. Key points from those pages:

• Head lice do not transmit any disease and therefore are not considered a health hazard (About Head Lice, June 4, 2024).
• Lice spread mainly by direct head-to-head contact. They crawl; they cannot hop or fly. Getting head lice is not related to cleanliness.
• Itching is the most common symptom, and it may take four to six weeks to appear the first time a person has lice. People with a light or first infestation may have no symptoms.
• Both over-the-counter and prescription medications treat head lice (Treatment of Head Lice, November 12, 2024). CDC does not recommend a specific product.
• Spending much time and money on housecleaning is not necessary to avoid reinfestation, and CDC says not to use fumigant sprays or fogs.

That last point matters for upsells. A clinic that sells home fogging, whole-house treatment packages or “lice-proof” home sprays as necessary is selling something CDC says is not needed, and in the case of fogs, says not to use.

“Guaranteed lice-free” and other guarantees

A guarantee is the lice clinic claim most likely to mislead when its terms sit in small print. The FTC’s guides on warranty and guarantee advertising were written for products, but they show how the FTC reads the words, and the FTC Act’s ban on deceptive practices (15 USC 45) applies to services too.

• Say what is guaranteed. “Lice-free” could mean no live lice at the end of the visit, no live lice at a follow-up check, or no lice ever again. Name the one you mean.
• Say the conditions. Under 16 CFR 239.3(b), an ad that mentions a satisfaction guarantee should disclose any material limitations or conditions clearly and prominently. For lice, conditions are usually a follow-up check by a date, treating all household members, and following home instructions.
• Say the remedy. A free re-treatment is different from a refund. Under 16 CFR 239.3(a), “money back guarantee” should be used only if you refund the full purchase price at the purchaser’s request.
• Keep the written terms available. 16 CFR 239.2 asks ads that mention a guarantee to tell buyers where they can see the full written terms before they buy. On a website, link them next to the claim.

Avoid “100% guaranteed” and “lice-free for life.” CDC lists reinfestation after successful treatment as a reason treatment fails, and a child can pick up lice again at school or camp the following week. No service controls that. Our guide to money-back guarantees in healthcare ads covers guarantee terms in more detail.

“One visit” and “done in an hour”

CDC’s treatment page says some medicines kill lice and eggs and usually do not need retreatment, while others kill lice but not eggs, so retreatment is recommended about a week later. It also recommends checking hair and removing nits and lice every 2 to 3 days for the next 2 to 3 weeks after each treatment, and lists reinfestation, misdiagnosis and not following instructions as reasons treatment fails.

So “one visit” is a claim about results across several weeks, not about the length of the appointment. If your method usually takes one appointment plus a follow-up check, say that. If your one-visit claim depends on a specific method, have evidence for that method’s results, not just your own impressions. Under 15 USC 55(a)(1), whether an ad is misleading depends partly on what it fails to reveal, such as a required follow-up visit or home combing.

“Pesticide-free,” “natural” and “non-toxic”

Parents ask for these words, and the rules on them are specific.

• “Pesticide-free.” True only if nothing you apply kills lice chemically. CDC’s clinical care page notes that the drugs used to treat lice are insecticides. If your clinic uses any lice-killing product, even one made from a plant extract, “pesticide-free” is likely false.
• “Natural.” CDC describes pyrethrins, an over-the-counter ingredient, as naturally occurring extracts from the chrysanthemum flower, and warns that people allergic to chrysanthemums or ragweed should avoid them. Natural does not mean free of insecticide or free of risk.
• “Non-toxic” and “safe for kids.” Under 16 CFR 260.10, a non-toxic claim likely conveys that the product or service is non-toxic for humans and the environment, and needs competent and reliable scientific evidence or a clear qualification. “Safe” is also a health claim that needs evidence under the FTC guidance.
• Home remedies. CDC says it does not have scientific evidence that suffocating lice with mayonnaise, olive oil, margarine, butter or similar substances is an effective treatment. Do not present these as proven, and do not sell oils or rinses with treatment claims you cannot support.

Accurate alternatives: “We remove lice and nits by combing. We do not use prescription lice medicine.” or “Our rinse contains [ingredient]; ask us for the label.” Describe what you do rather than what you avoid.

Heated-air devices and “FDA-approved”

FDA classifies lice removal kits under 21 CFR 880.5960: a comb or comb-like device intended to remove and/or kill lice and nits from head and body hair, battery operated or not. It is Class I and exempt from premarket notification, subject to limitations. In FDA’s 510(k) database, product code LJL lists 11 clearances, from October 13, 1982 to May 8, 2017.

Two of those clearances are for a heated-air lice device, cleared on March 10, 2009 for prescription use and on December 16, 2009 for non-prescription use. The cleared intended use is to kill or remove lice and lice eggs in the head hair of adults and children 4 years of age and older. If your clinic uses a heated-air device, three points follow:

• Say “FDA-cleared,” not “FDA-approved.” 21 CFR 807.97 says a 510(k) determination does not in any way denote official approval, and any representation that creates an impression of official approval is misleading.
• Stay inside the cleared use: head hair, adults and children 4 and older. Claims about younger children, body lice, eyelashes or home use go beyond it.
• “Kills 100% of lice and eggs” is a performance claim. Use only results you can document from the clearance summary or your own reliable data, and do not imply a device does the whole job if you also comb.

School clearance and “no-nit” letters

Some clinics sell “school clearance” or “nit-free certificates.” CDC’s page for caregivers says students with head lice do not need to be sent home early, can return to class after beginning appropriate treatment, and that nits may stay in hair after successful treatment. It also says both the American Academy of Pediatrics and the National Association of School Nurses advocate discontinuing “no-nit” policies, and that misdiagnosis of nits is very common during nit checks by nonmedical professionals.

If a school asks for a note, you can describe what you did on what date. Do not claim the note is required by law, do not imply you are a medical provider if you are not, and do not use fear of school exclusion as the main selling point. If you run a school-based health center, keep lice messaging in line with the school’s own policy and CDC’s guidance.

Who does the work, and the word “clinic”

• “Clinic” and “treatment.” A storefront that combs hair may still call itself a lice clinic. If no licensed health professional is involved, say so plainly, so parents do not assume a medical visit. The FTC looks at the net impression of the whole ad (FTC guidance; 15 USC 45).
• Titles. “Certified lice technician” describes private training. Say who issued it. Do not use “nurse” or “medical” unless a licensed nurse or clinician actually provides the service.
• Doctor or nurse endorsements. “Pediatrician recommended” or “recommended by school nurses” needs a real expert who actually evaluated your service. Under 16 CFR 255.3, an expert endorsement must be supported by an actual exercise of the expertise the endorser is represented as having.
• Prescription products. CDC lists several prescription lice medicines. A non-medical clinic cannot prescribe them, so do not imply that a visit includes prescription treatment.

In-home services face the same rules. See our guide to house call practice marketing for service-area and travel-fee wording.

Reviews, before-and-after photos and stories

Under 16 CFR 255.2(a), an advertiser needs substantiation for what a consumer endorsement conveys, as if it made the claim itself. Under 16 CFR 255.2(b), an endorsement about a key result is likely to be read as typical unless the ad clearly and conspicuously discloses the generally expected results.

• “The staff were kind and my daughter was relaxed” describes the visit. It is easy to use.
• “Lice gone in one visit, never came back” is a one-visit and permanence claim you would be making yourself.
• Photos of a child’s scalp, hair or face are images of a minor. Get written permission from a parent, and do not show a child in a way that could embarrass them at school.
• Do not post a family’s name, school or neighborhood with a lice story.

See our guide to patient testimonials and before-and-after photos.

Prices, packages and insurance wording

• Per-head pricing. If the price is per person, per hour, or per head of hair length, say so next to the number. Add any travel fee for in-home visits.
• Family packages. “Family check and treatment” should say how many people and whether follow-up visits are included.
• Former prices. “Was $250, now $150” needs a former price you actually offered in good faith for a reasonably substantial period (16 CFR 233.1(a)).
• Insurance and HSA wording. Do not say a service is covered or reimbursable unless you have confirmed it for that plan or account.

See our guide to advertising cash prices.

An example (made up)

This illustration is invented. A lice clinic posts: “Guaranteed lice-free in ONE visit! 100% pesticide-free, non-toxic and safe for all ages. FDA-approved heated-air technology. No-nit school clearance included. Don’t let lice spread through your whole house! Was $299, now $149.”

Fixes: “Guaranteed lice-free in ONE visit” becomes “One treatment visit plus a free check 7 days later. If we find live lice at that check, we re-treat at no charge. Terms: [link].” “100% pesticide-free, non-toxic and safe for all ages” comes off unless every product used meets 16 CFR 260.10 and the safety evidence exists; the cleared device use is for children 4 and older. “FDA-approved” becomes “FDA-cleared” (21 CFR 807.97). “No-nit school clearance” becomes “a dated note of the service we provided, if your school asks.” “Spread through your whole house” comes off; CDC says lice do not survive long off the head and housecleaning beyond basic steps is not necessary. The former price stays only if families actually paid $299 for a reasonable period. A version that holds up: “Head lice removal for kids and adults. Combing plus a heated-air device cleared by FDA for ages 4 and up. Free follow-up check at 7 days. $149 per person.”

Checklist

• Guarantees name what is guaranteed, for how long, the conditions and the remedy, near the claim (16 CFR 239.2, 239.3; 15 USC 45).
• No “lice-free for life” or “100%” claims.
• “One visit” claims disclose any follow-up visit or home combing (15 USC 55(a)(1); CDC treatment page).
• No “pesticide-free,” “natural” or “non-toxic” wording you cannot support (16 CFR 260.10).
• “FDA-cleared” not “FDA-approved,” and only the cleared use (21 CFR 807.97, 880.5960).
• No fear-based housecleaning or fogging upsells (CDC).
• School notes described as what they are; nothing implying a legal requirement.
• Credentials and expert endorsements real and stated plainly (16 CFR 255.3).
• Reviews about the experience; parental consent for any image of a child (16 CFR 255.2).
• Prices per person, follow-ups and former prices real and clear (16 CFR 233.1).

How we help

We build pages and ads for pediatric and family practices and the services around them, with claims checked against the sources above: website design, healthcare SEO for searches like “lice removal near me,” and lead generation campaigns with guarantee terms that hold up. We do not give legal opinions and we are not a law firm.

Sources

• CDC: About Head Lice (June 4, 2024)
• CDC: Treatment of Head Lice (November 12, 2024)
• CDC: Clinical Care of Head Lice (January 31, 2025)
• CDC: Providing Care for Individuals with Head Lice (February 21, 2024)
• 21 CFR 880.5960: Lice removal kit
• 21 CFR 807.97: Misbranding by reference to premarket notification
• FDA 510(k) database: K093144 (December 16, 2009)
• FTC: Health Products Compliance Guidance (December 2022)
• 16 CFR part 239: Guides for the advertising of warranties and guarantees
• 16 CFR 260.10: Non-toxic claims
• 16 CFR 255.2: Consumer endorsements
• 16 CFR 255.3: Expert endorsements
• 16 CFR 233.1: Former price comparisons
• 15 USC 45: Unfair methods of competition unlawful
• 15 USC 52: Dissemination of false advertisements
• 15 USC 55: Additional definitions

More in Cash-pay, aesthetic and wellness care